Drug Type Small molecule drug |
Synonyms LFF 269, LFF269 |
Target |
Action inhibitors |
Mechanism ALDOS inhibitors(Cytochrome P450 11B2 inhibitors) |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
License Organization- |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Molecular FormulaC18H17ClN4O2S |
InChIKeyUNQXIRZDOXDTMH-UHFFFAOYSA-N |
CAS Registry1202550-93-3 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Essential Hypertension | Phase 2 | United States | 01 May 2011 |